| Original language | English |
|---|---|
| Pages (from-to) | 444-450 |
| Number of pages | 7 |
| Journal | Nature Genetics |
| Volume | 49 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2017 |
Cite this
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer. / Magnani, L.; Frigè, G.; Gadaleta, R.M.; Corleone, G.; Fabris, S.; Kempe, H.; Verschure, P.J.; Barozzi, I.; Vircillo, V.; Hong, S.-P.; Perone, Y.; Saini, M.; Trumpp, A.; Viale, G.; Neri, A.; Ali, S.; Colleoni, M.A.; Pruneri, G.; Minucci, S.
In: Nature Genetics, Vol. 49, No. 3, 2017, p. 444-450.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
AU - Magnani, L.
AU - Frigè, G.
AU - Gadaleta, R.M.
AU - Corleone, G.
AU - Fabris, S.
AU - Kempe, H.
AU - Verschure, P.J.
AU - Barozzi, I.
AU - Vircillo, V.
AU - Hong, S.-P.
AU - Perone, Y.
AU - Saini, M.
AU - Trumpp, A.
AU - Viale, G.
AU - Neri, A.
AU - Ali, S.
AU - Colleoni, M.A.
AU - Pruneri, G.
AU - Minucci, S.
N1 - Cited By :4 Export Date: 5 March 2018
PY - 2017
Y1 - 2017
U2 - 10.1038/ng.3773
DO - 10.1038/ng.3773
M3 - Article
VL - 49
SP - 444
EP - 450
JO - Nature Genetics
JF - Nature Genetics
SN - 1061-4036
IS - 3
ER -